UNITY Biotechnology, Inc. to Participate in the H.C. Wainwright Ophthalmology Virtual ConferenceGlobeNewsWire • 08/16/21
UNITY Biotechnology, Inc. Reports Second Quarter 2021 Financial Results and Business UpdatesGlobeNewsWire • 08/10/21
Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325PRNewsWire • 07/28/21
UNITY Biotechnology to Host Investor Call with Retinal Expert Robert Bhisitkul, M.D., Ph.D., to Discuss Recent Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye DiseaseGlobeNewsWire • 07/23/21
UNITY Biotechnology, Inc. Reports First Quarter 2021 Financial Results and Business UpdatesGlobeNewsWire • 05/11/21
UNITY Biotechnology Presents UBX1325 Data Demonstrating Improvement in Retinal Vasculature and Function in Preclinical Models of Diabetic Retinopathy Eye DiseasesGlobeNewsWire • 05/01/21
UNITY Biotechnology to Present Preclinical Data on Clinical Candidate Molecule UBX1325 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual MeetingGlobeNewsWire • 04/28/21
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Business UpdatesGlobeNewsWire • 03/23/21
Are Options Traders Betting on a Big Move in Unity Biotechnology (UBX) Stock?Zacks Investment Research • 01/12/21
Ascentage Pharma's Licensee UNITY Biotechnology Announces Milestone Reached in Clinical Development of Treatments for Age-Related Disease, Leading to Milestone PaymentPRNewsWire • 12/22/20
UNITY Biotechnology Announces Appointment of Clinical Development and Industry Veteran Gilmore O'Neill, M.B., to the Board of DirectorsGlobeNewsWire • 12/14/20
UNITY Biotechnology, Inc. Reports Third Quarter 2020 Financial Results and Clinical Program UpdatesGlobeNewsWire • 11/04/20
UNITY Biotechnology Announces First Patient Dosed in Phase 1 Study of UBX1325 in Diabetic Macular EdemaGlobeNewsWire • 10/12/20
UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and NeurologyGlobeNewsWire • 09/15/20
UNITY Biotechnology to Participate in Upcoming September Investor ConferencesGlobeNewsWire • 09/04/20
UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial OfficerGlobeNewsWire • 08/31/20